HYRNUO

Product NDC
50419-397
11-digit product format
504190397
Labeler code
50419
Product ID
50419-397_2ba86679-0db2-44b4-86d1-e69413e24762
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
SEVABERTINIB
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Bayer HealthCare Pharmaceuticals Inc.
Application
NDA219972
Marketing category
NDA
Marketing start
2025-11-19
Substance
SEVABERTINIB
Active strength
10 mg/1
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N219972-001HYRNUOSEVABERTINIB10MGTABLET / ORALRLD, RS2025-11-19

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N219972-001104280632035-10-10Drug substance, Drug product2025-12-09
N219972-001126798362043-11-14U-4582Drug substance, Drug product2026-08-10

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 3 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
N219972-001NCE2030-11-19
N219972-001ODE-5602032-11-19
N219972-001ODE-5612033-09-09

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N219972-001HYRNUO10MGTABLET / ORALRLD, RS2025-11-19d4dbc9d85df4…
2026-10-15 13:18:302026-09N219972-001HYRNUO10MGTABLET / ORALRLD, RS2025-11-19c2088c7a36db…
2026-09-14 22:38:342026-08N219972-001HYRNUO10MGTABLET / ORALRLD, RS2025-11-1984e616aacf4f…
2026-08-18 06:07:402026-07N219972-001HYRNUO10MGTABLET / ORALRLD, RS2025-11-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N219972-001HYRNUO10MGTABLET / ORALRLD, RS2025-11-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N219972-001HYRNUO10MGTABLET / ORALRLD, RS2025-11-1931067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N219972-001HYRNUO10MGTABLET / ORALRLD, RS2025-11-19a50c72e98297…

Observed Orange Book patent history#

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-11-14 07:37:172026-10N219972-001104280632035-10-10Drug substance, Drug product2025-12-09d4dbc9d85df4…
2026-11-14 07:37:172026-10N219972-001126798362043-11-14U-4582Drug substance, Drug product2026-08-10d4dbc9d85df4…
2026-10-15 13:18:302026-09N219972-001104280632035-10-10Drug substance, Drug product2025-12-09c2088c7a36db…
2026-10-15 13:18:302026-09N219972-001126798362043-11-14U-4582Drug substance, Drug product2026-08-10c2088c7a36db…
2026-09-14 22:38:342026-08N219972-001104280632035-10-10Drug substance, Drug product2025-12-0984e616aacf4f…
2026-09-14 22:38:342026-08N219972-001126798362043-11-14U-4582Drug substance, Drug product2026-08-1084e616aacf4f…
2026-08-18 06:07:402026-07N219972-001104280632035-10-10Drug substance, Drug product2025-12-09caaa826d4ba7…
2026-08-18 06:07:402026-07N219972-001126798362043-11-14U-4582Drug substance, Drug product2026-08-10caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N219972-001104280632035-10-10Drug substance, Drug product2025-12-09011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N219972-001104280632036-01-25Drug substance, Drug product2025-12-0931067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N219972-001104280632035-10-10Drug substance, Drug product2025-12-09a50c72e98297…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-11-14 07:37:172026-10N219972-001NCE2030-11-19d4dbc9d85df4…
2026-11-14 07:37:172026-10N219972-001ODE-5602032-11-19d4dbc9d85df4…
2026-11-14 07:37:172026-10N219972-001ODE-5612033-09-09d4dbc9d85df4…
2026-10-15 13:18:302026-09N219972-001NCE2030-11-19c2088c7a36db…
2026-09-14 22:38:342026-08N219972-001NCE2030-11-1984e616aacf4f…
2026-08-18 06:07:402026-07N219972-001NCE2030-11-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N219972-001NCE2030-11-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N219972-001NCE2030-11-1931067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N219972-001NCE2030-11-19a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
HYRNUO
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SEVABERTINIB10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2A7VPM5RWHInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2728192Internal RxNorm lookup
2728198Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
d7a11334-6e7a-445b-9a16-bdcd9acbe61fAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50419-397-01HYRNUO120 in 1 BOTTLETABLET, FILM COATED1208

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50419-397-01EA - Each50419-397d35cc56d-5bd4-4056-8d40-5356ec502f6712025-12-16

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HYRNUOSEVABERTINIBBayer HealthCare Pharmaceuticals Inc.d7a11334-6e7a-445b-9a16-bdcd9acbe61f2026-09-17Warnings, Adverse reactionsExact identifier
application applno (NDA): 219972
application number: NDA219972
ndc (product): 50419-397

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2728198HYRNUO 10 MG Oral TabletPSNd7a11334-6e7a-445b-9a16-bdcd9acbe61f8
2728192sevabertinib 10 MG Oral TabletPSNd7a11334-6e7a-445b-9a16-bdcd9acbe61f8
2728198sevabertinib 10 MG Oral Tablet [Hyrnuo]SBDd7a11334-6e7a-445b-9a16-bdcd9acbe61f8
2728192sevabertinib 10 MG Oral TabletSCDd7a11334-6e7a-445b-9a16-bdcd9acbe61f8
2728198Hyrnuo 10 MG Oral TabletSYd7a11334-6e7a-445b-9a16-bdcd9acbe61f8

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
50419-397-0150419039701120 TABLET, FILM COATED in 1 BOTTLE (50419-397-01) 2025-11-19NoNoCurrent